Nicholas Daniel sold $72k of ETSY
CHIEF PRODUCT OFFICER at ETSY INC. 1,500 shares at an average of $48.24, traded Apr 1, 2025, filed Apr 3, 2025.
Score components
- +15RoleOfficer
- +8Trade size$72k at market
- 0Share of holdings soldSold 4.1% of holdings
- +15Cluster4 insiders selling within 14 days
- +10Role exitThe filing reports the insider leaving
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-010038, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | MOption exercise Common Stock10b5-1 | +25,559 | $0.00 | $0 | 46,257 | Apr 3, 2025 |
| Apr 1, 2025 | FTax withholding Common Stock10b5-1 | -9,935 | $48.53 | $482k | 36,322 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -151 | $47.67 | $7,198 | 36,171 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -1,229 | $48.26 | $59k | 34,942 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -120 | $48.79 | $5,855 | 34,822 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -118 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,572 | $0.00 | $0 | 3,146 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,055 | $0.00 | $0 | 12,167 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,501 | $0.00 | $0 | 18,001 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,909 | $0.00 | $0 | 46,907 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -501 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Performance Stock Unitsderivative10b5-1 | -3,686 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Performance Stock Unitsderivative10b5-1 | -7,217 | $0.00 | $0 | 7,219 | Apr 3, 2025 |
Related signals
Other insiders at ETSY INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | ETSY INC | Josh Silverman Chief Executive Officer | $28k 383 shares | -0% | |
| 40Moderate | ETSY INC | Merilee Buckley CHIEF ACCOUNTING OFFICER | $100k 1,396 shares | -100% | |
| 34Weak | ETSY INC | Richard Edward Colburn III Chief Product & Tech Officer | $319k 4,472 shares | -41% | |
| 6Weak | ETSY INC | Josh Silverman Chief Executive Officer | $151k 2,090 shares | -1% | |
| 28Weak | ETSY INC | Richard Edward Colburn III Chief Product & Tech Officer | $239k 2,913 shares | -31% | |
| 35Weak | ETSY INC | Frederick R Wilson director | $1.6M 20,000 shares | -5% | |
| 20Weak | ETSY INC | Josh Silverman Chief Executive Officer | $1.1M 13,367 shares | -5% | |
| 28Weak | ETSY INC | Josh Silverman Chief Executive Officer | $1.2M 21,666 shares | -22% | |
| 10Weak | ETSY INC | Marla J Blow director | $16k 300 shares | -3% | |
| 52Moderate | ETSY INC | Richard Edward Colburn III Chief Product & Tech Officer | $185k 3,200 shares | -42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.